Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001104659-18-019916
Filing Date
2018-03-26
Accepted
2018-03-23 20:17:29
Documents
90
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-KT a18-5477_110kt.htm 10-KT 1850544
2 EX-14.1 a18-5477_1ex14d1.htm EX-14.1 45915
3 EX-21.1 a18-5477_1ex21d1.htm EX-21.1 3575
4 EX-23.1 a18-5477_1ex23d1.htm EX-23.1 2841
5 EX-31.1 a18-5477_1ex31d1.htm EX-31.1 12649
6 EX-31.2 a18-5477_1ex31d2.htm EX-31.2 12632
7 EX-32.1 a18-5477_1ex32d1.htm EX-32.1 6235
8 EX-32.2 a18-5477_1ex32d2.htm EX-32.2 6218
  Complete submission text file 0001104659-18-019916.txt   8079438

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ctrv-20171231.xml EX-101.INS 1681900
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20171231.xsd EX-101.SCH 71679
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20171231_cal.xml EX-101.CAL 53136
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20171231_def.xml EX-101.DEF 280997
13 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20171231_lab.xml EX-101.LAB 590560
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20171231_pre.xml EX-101.PRE 467330
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 001-36856 | Film No.: 18711454
SIC: 2834 Pharmaceutical Preparations